Oncology Research

The FusionPlex Oncology Research panel is a targeted next-generation sequencing (NGS) product to simultaneously detect and identify fusions and other mutations associated with 75 genes found in ribonucleic acid (RNA) transcripts that are linked to various cancers. This panel is extensive and purpose-built to advance fusion discovery, including research efforts in the area of Ph-like acute lymphoblastic leukemia (ALL) fusions.

Thank You

Comprehensive Fusion Detection

AMP chemistry utilizes open-ended targeted amplification to identify gene fusions whether or not the fusion partner is known.

Splice Variants

Detect cancer-associated isoforms and alternative splicing events.

Low Input

Purpose-built for wide sample type compatibility, including low-input and degraded samples such as FFPE tissue.

Simple, Lyophilized Workflow

Easy-to-handle lyophilized reagents and a simple workflow to minimize errors and reduce turn-around time.

Properties

Specifications

Gene Targets

75 Input Nucleic Acid Required*

≤10ng

Unique Molecular On-Target%

>96%

Hands-on Time

2.5 hours

Total Time

9 Hour

Platform

Illumina® and Ion Torrent™

Sample Types

Fresh frozen and FFPE

Input recommendations for FFPE samples vary depending on PreSeq® RNA QC score; 50ng input recommended in absence of PreSeq screening

LEGEND

SNV/Indel
Fusion, splicing or exon-skipping

Product Information

ILLUMINA®

ION TORRENT™

Archer® Analysis

Contact Us

Need to modify your panel?

Add any of our wet lab-validated designs to this panel with Archer Assay Designer to build an assay that fits your exact requirements.

Learn More

Ready to Start?
Get A Quote

For Research Use Only. Not for use in diagnostic procedures.

Ready to Start? Request Demo Data